neurological biomarkers market

Global Neurological Biomarkers Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-02-25
  • Report ID: 61411
  • Pages: 94
  • Format: prudent report format

Snapshot

The global Neurological Biomarkers market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neurological Biomarkers by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Proteomics
Genomics
Imaging
Bioinformatics
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Thermo Fisher
Merck
Bio-Rad Laboratories
Roche
QIAGEN
Athena Diagnostics
Myriad RBM
Cisbio Bioassays
Wuxi APP
BGI
Aepodia
Genewiz
Proteome Sciences

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Diagnostics
Drug Discovery
Personalized Medicine
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Neurological Biomarkers Industry
Figure Neurological Biomarkers Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Neurological Biomarkers
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Neurological Biomarkers
1.2.2 Downstream
Table Application Segment of Neurological Biomarkers
Table Global Neurological Biomarkers Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Neurological Biomarkers Market by Type
3.1 By Type
3.1.1 Proteomics
Table Major Company List of Proteomics
3.1.2 Genomics
Table Major Company List of Genomics
3.1.3 Imaging
Table Major Company List of Imaging
3.1.4 Bioinformatics
Table Major Company List of Bioinformatics
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Neurological Biomarkers Market 2016-2020, by Type, in USD Million
Figure Global Neurological Biomarkers Market Growth 2016-2020, by Type, in USD Million
Table Global Neurological Biomarkers Market 2016-2020, by Type, in Volume
Figure Global Neurological Biomarkers Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Neurological Biomarkers Market Forecast 2021-2026, by Type, in USD Million
Table Global Neurological Biomarkers Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Thermo Fisher (Company Profile, Sales Data etc.)
4.1.1 Thermo Fisher Profile
Table Thermo Fisher Overview List
4.1.2 Thermo Fisher Products & Services
4.1.3 Thermo Fisher Business Operation Conditions
Table Business Operation of Thermo Fisher (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Merck (Company Profile, Sales Data etc.)
4.2.1 Merck Profile
Table Merck Overview List
4.2.2 Merck Products & Services
4.2.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bio-Rad Laboratories (Company Profile, Sales Data etc.)
4.3.1 Bio-Rad Laboratories Profile
Table Bio-Rad Laboratories Overview List
4.3.2 Bio-Rad Laboratories Products & Services
4.3.3 Bio-Rad Laboratories Business Operation Conditions
Table Business Operation of Bio-Rad Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Roche (Company Profile, Sales Data etc.)
4.4.1 Roche Profile
Table Roche Overview List
4.4.2 Roche Products & Services
4.4.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 QIAGEN (Company Profile, Sales Data etc.)
4.5.1 QIAGEN Profile
Table QIAGEN Overview List
4.5.2 QIAGEN Products & Services
4.5.3 QIAGEN Business Operation Conditions
Table Business Operation of QIAGEN (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Athena Diagnostics (Company Profile, Sales Data etc.)
4.6.1 Athena Diagnostics Profile
Table Athena Diagnostics Overview List
4.6.2 Athena Diagnostics Products & Services
4.6.3 Athena Diagnostics Business Operation Conditions
Table Business Operation of Athena Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Myriad RBM (Company Profile, Sales Data etc.)
4.7.1 Myriad RBM Profile
Table Myriad RBM Overview List
4.7.2 Myriad RBM Products & Services
4.7.3 Myriad RBM Business Operation Conditions
Table Business Operation of Myriad RBM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Cisbio Bioassays (Company Profile, Sales Data etc.)
4.8.1 Cisbio Bioassays Profile
Table Cisbio Bioassays Overview List
4.8.2 Cisbio Bioassays Products & Services
4.8.3 Cisbio Bioassays Business Operation Conditions
Table Business Operation of Cisbio Bioassays (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Wuxi APP (Company Profile, Sales Data etc.)
4.9.1 Wuxi APP Profile
Table Wuxi APP Overview List
4.9.2 Wuxi APP Products & Services
4.9.3 Wuxi APP Business Operation Conditions
Table Business Operation of Wuxi APP (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 BGI (Company Profile, Sales Data etc.)
4.10.1 BGI Profile
Table BGI Overview List
4.10.2 BGI Products & Services
4.10.3 BGI Business Operation Conditions
Table Business Operation of BGI (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Aepodia (Company Profile, Sales Data etc.)
4.11.1 Aepodia Profile
Table Aepodia Overview List
4.11.2 Aepodia Products & Services
4.11.3 Aepodia Business Operation Conditions
Table Business Operation of Aepodia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Genewiz (Company Profile, Sales Data etc.)
4.12.1 Genewiz Profile
Table Genewiz Overview List
4.12.2 Genewiz Products & Services
4.12.3 Genewiz Business Operation Conditions
Table Business Operation of Genewiz (Sales Revenue, Cost, Gross Margin)
4.13 Proteome Sciences (Company Profile, Sales Data etc.)
4.13.1 Proteome Sciences Profile
Table Proteome Sciences Overview List
4.13.2 Proteome Sciences Products & Services
4.13.3 Proteome Sciences Business Operation Conditions
Table Business Operation of Proteome Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Neurological Biomarkers Sales Revenue 2016-2020, by Company, in USD Million
Table Global Neurological Biomarkers Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Neurological Biomarkers Sales Revenue Share in 2020, by Company, in USD Million
Table Global Neurological Biomarkers Sales Volume 2016-2020, by Company, in Volume
Table Global Neurological Biomarkers Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Neurological Biomarkers Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Neurological Biomarkers Market Concentration, in 2020
Figure Europe Neurological Biomarkers Market Market Concentration, in 2020
Figure Asia-Pacific Neurological Biomarkers MMarket Concentration, in 2020
Figure South America Neurological Biomarkers Market Concentration, in 2020
Figure Middle East & Africa Neurological Biomarkers Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Diagnostics
Figure Neurological Biomarkers Demand in Diagnostics, 2016-2020, in USD Million
Figure Neurological Biomarkers Demand in Diagnostics, 2016-2020, in Volume
6.1.2 Demand in Drug Discovery
Figure Neurological Biomarkers Demand in Drug Discovery, 2016-2020, in USD Million
Figure Neurological Biomarkers Demand in Drug Discovery, 2016-2020, in Volume
6.1.3 Demand in Personalized Medicine
Figure Neurological Biomarkers Demand in Personalized Medicine, 2016-2020, in USD Million
Figure Neurological Biomarkers Demand in Personalized Medicine, 2016-2020, in Volume
6.1.4 Demand in Others
Figure Neurological Biomarkers Demand in Others, 2016-2020, in USD Million
Figure Neurological Biomarkers Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Neurological Biomarkers Demand Forecast 2021-2026, by Application, in USD Million
Figure Neurological Biomarkers Market Growth 2021-2026, by Application, in USD Million
Figure Neurological Biomarkers Market Share in 2026, by Application, in USD Million
Table Neurological Biomarkers Demand Forecast 2021-2026, by Application, in Volume
Table Neurological Biomarkers Market Growth 2021-2026, by Application, in Volume
Table Neurological Biomarkers Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Neurological Biomarkers Production 2016-2020, by Region, in USD Million
Table Neurological Biomarkers Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Neurological Biomarkers Market 2016-2020, by Region, in USD Million
Table Global Neurological Biomarkers Market Share 2016-2020, by Region, in USD Million
Table Global Neurological Biomarkers Market 2016-2020, by Region, in Volume
Table Global Neurological Biomarkers Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Neurological Biomarkers Market Size and Growth 2016-2020, in USD Million
Figure North America Neurological Biomarkers Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Neurological Biomarkers Market Size 2016-2020, by Country, in USD Million
Table North America Neurological Biomarkers Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Neurological Biomarkers Market Size and Growth 2016-2020, in USD Million
Figure Europe Neurological Biomarkers Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Neurological Biomarkers Market Size 2016-2020, by Country, in USD Million
Table Europe Neurological Biomarkers Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Neurological Biomarkers Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Neurological Biomarkers Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Neurological Biomarkers Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Neurological Biomarkers Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Neurological Biomarkers Market Size and Growth 2016-2020, in USD Million
Figure South America Neurological Biomarkers Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Neurological Biomarkers Market Size 2016-2020, by Country, in USD Million
Table South America Neurological Biomarkers Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Neurological Biomarkers Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Neurological Biomarkers Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Neurological Biomarkers Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Neurological Biomarkers Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Neurological Biomarkers Market Forecast 2021-2026, by Region, in USD Million
Table Neurological Biomarkers Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.